Vı́ctor Tapias

A highly reproducible rotenone model of Parkinson's disease

Jason R. Cannon, Vı́ctor Tapias, Hye Mee Na et al. · Neurobiology of Disease · 2009 · 793 citations · Full text

Life Sciences, Neurobiology, Neuroscience +10

shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model

Alevtina Zharikov, Jason R. Cannon, Vı́ctor Tapias et al. · Journal of Clinical Investigation · 2015 · 181 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Inhibition of neuronal nitric oxide synthase activity by <i>N</i>¹‐acetyl‐5‐methoxykynuramine, a brain metabolite of melatonin

Josefa León, Germaine Escames, María Isabel Rodríguez et al. · Journal of Neurochemistry · 2006 · 158 citations

Life Sciences, Neuroscience, Pharmacology +11

Melatonin counteracts inducible mitochondrial nitric oxide synthase‐dependent mitochondrial dysfunction in skeletal muscle of septic mice

Germaine Escames, Luís C. López, Vı́ctor Tapias et al. · Journal of Pineal Research · 2005 · 152 citations · Full text

Life Sciences, Pharmacology, Physiology +14

Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production

Vı́ctor Tapias, Kelvin C. Luk, Laurie H. Sanders et al. · Cellular and Molecular Life Sciences · 2017 · 126 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17